Stay updated on Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page
- CheckyesterdayChange DetectedThe revision label on the page changed from v3.6.4 to v3.6.5, signaling a new version of the page content or template. This appears to be a routine, minor update that does not modify the study details or user-facing content.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4 on the page. This reflects a minor update to the page's metadata and does not affect core content or behavior.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2, indicating an updated revision tag on the page.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page revision changed from v3.6.0 to v3.6.2. This indicates a minor update to the ClinicalTrials.gov entry, likely related to QC or editorial adjustments rather than changes to the study content.SummaryDifference0.1%

- Check58 days agoChange DetectedRecruitment status on the study page was updated to indicate that no participants are being recruited, and several new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The page version note was updated from v3.5.5 to v3.6.0, and the header label for interventions was standardized from 'Intervention / Treatment' to 'Intervention/Treatment'.SummaryDifference0.4%

- Check65 days agoChange DetectedThe page shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This indicates a minor update to the page's revision history rather than a substantive change to the study details.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page.